Company: ARWR
Filing Date: 2025-01-29
Form Type: DEF 14A
Source: 0001628280-25-002848
Chunk: 53

Company: ARROWHEAD PHARMACEUTICALS, INC.
Filing Date: 2025-01-29
Form: DEF 14A
Chunk 53
---
 This pay ratio is a reasonable estimate calculated by a method consistent with the SEC requirements, described above, based on our payroll and employment records. As a result of a variety of factors, including employee populations, potential differences in the components used for the CACM, compensation philosophies and certain assumptions, pay ratios reported by other companies may not be comparable to our pay ratio. The pay ratio is not utilized by our management or our compensation committee for compensation-related decisions.

| 52 |

2025 PROXY STATEMENT Executive Compensation Pay Versus Performance

As required by Section 953(a) of the Dodd-Frank Wall Street Reform and Consumer Protection Act, and Item 402(v) of Regulation S-K, we are providing the following information about the relationship between executive “compensation actually paid” and certain financial performance of the Company. This information has been prepared in accordance with Item 402(v) and does not necessarily reflect the actual amount of compensation earned by or paid to our named executive officers ("NEOs") for the applicable year. Please refer to the Compensation Discussion and Analysis section of this proxy statement for a discussion of our executive compensation program objectives and the ways in which we align executive compensation with performance.

| Year (a) |     | Summary Compensation Table Total for PEO (1)(b) |     | Compensation Actually Paid to PEO (2)(c) |     | Average Summary Compensation Table Total for Non-PEO NEOs (1)(d) |     | Average Compensation Actually Paid to Non-PEO NEOs (2) (e) |     | Value of Initial Fixed $100 Investment Based On: 
                  Total Shareholder Return (3)(f) |     | Peer Group Total Shareholder Return (4)(g) |     |   (in thousands) 
 Net Loss (5) (h) |     | Company Selected Measure (6)(i) |   |
|:---------|:----|------------------------------------------------:|:----|-----------------------------------------:|:----|-----------------------------------------------------------------:|:----|-----------------------------------------------------------:|:----|-------------------------------------------------:|:----|-------------------------------------------:|:----|-----------------:|:----|:--------------------------------|:--|
| 2024     |     |                                     $12,423,473 |     |                              -$5,232,848 |     |                                                       $3,493,347 |     |                                                 $2,614,573 |     |                                              $31 |     |                                        $94 |     |        -$599,493 |